Gallium citrate uptake is a marker of breast malignancy: True or false?

Nuclear Medicine Review

Volumn 10, Issue 1, 2007, Pages 21-22

  Taher, Muhammed A ^a   Navalkissoor, Shanauk ^a   Hilson, Andrew J W ^a   Buscombe, John R ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

67Gallium citrate; Breast adenoma

Indexed keywords

CITRIC ACID; DIAGNOSTIC AGENT; GALLIUM; GALLIUM CITRATE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BREAST TUMOR; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBROADENOMA; HUMAN; LABORATORY DIAGNOSIS; RADIOGRAPHY; SCINTISCANNING;

ADULT; BREAST NEOPLASMS; CITRATES; FALSE POSITIVE REACTIONS; FEMALE; FIBROADENOMA; GALLIUM; GALLIUM RADIOISOTOPES; HUMANS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548545282     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. rd ed. Elsevier Mosby, Philadelphia 2006.
2. Jing JM, Kim EE, Moulopoulos L et al. Primary breast lymphoma detected with SPECT using Gallium-67-citrate. J Nucl Med 1995; 36: 236-237.
3. Dillehay GL, Papatheofanis F. Gallium imaging of tumors. In: Henkin RE, Boles MA, Dillehay GL, Halama JR, Karesh SM, Wagner RH, Zimmer AM (eds). Nuclear Medicine. Vol. II. Mosby-Year Book Inc., St. Louis 1996: 1463-1492.
4. 67Ga-citrate. J Nucl Med 1969; 10: 103-105.
5. 67Ga-citrate scanning. J Nucl Med 1972; 13: 196-201.
6. 67Gacitrate. J Nucl Med 1976; 16: 293.